## Abstract Antibodies to __E. coli__‐produced HIV‐1 __nef__, __rev__, __tat__, __vpu__, and __vpr__ proteins were measured by enzyme immunoassay in serial sets of sera from 72 men seroconverting for antibodies to HIV‐1 structural proteins, and from 190 initially symptom‐free men who were seroposit
HIV-1 variability and progression to AIDS: A longitudinal study
✍ Scribed by Dr. Josè Ramòn Fiore; Maria Luisa Calabró; Gioacchino Angarano; Anita De Rossi; Cecilia Fico; Giuseppe Pastore; Luigi Chieco Bianchi
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 504 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
HIV‐1 replicative activity and its relation to the clinical and immunological evolution of infection was studied in a group of 150 HIV‐1 seropositive Italian i.v. drug abusers over a 1 year period. HIV‐1 was isolated from 91 (60%) subjects; two groups of isolates were distinguished, according to replicative activity “in vitro” and ability to induce cytopathic effects in cell cultures, and were termed “rapid‐high” and “slow‐low” viruses, in agreement with other workers. Rapid‐high viruses were recovered more frequently from patients with ARC/AIDS, while slow‐low viruses seemed related to the asymptomatic period of infection. The replicative properties of HIV‐1 seem to affect strongly the course of disease. In fact, an important CD4 cell decline occurred in asymptomatic subjects with rapid‐high virus infection; asymptomatic subjects with negative viral cultures or with slow‐low viruses showed no such decline. Asymptomatic subjects with negative viral cultures had no signs of disease during the observation period, while 9% with slow‐low virus and 45% with rapid‐high virus progressed to AIDS.
📜 SIMILAR VOLUMES
A hypothesis is developed that circulatory exposure to alloantigens found on lymphocytes triggers a series of events leading to suppression of the cell-mediated arm of the immune system and, therefore, that such alloantigenic challenge can be an important cofactor promoting infection with the human
Little evidence exists on how to efficiently and effectively monitor HIV-disease progression in developing countries. Better understanding regarding cost-effective tests may help to resolve questions regarding treatment. A prospective cohort study was conducted with a 1-year follow-up period. Immune